NCM · Biotechnology

FLNA (FLNA) Stock

$0.99 +3.51% NCM: FLNA Healthcare

Valuation

MetricValue
Price$0.99
Market Cap$47.96M
P/E Ratio-0.66
P/B Ratio0.82
P/S Ratio0.00
EPS (TTM)$-1.88
52-Week High$4.98
52-Week Low$0.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-122.97%
ROA-77.12%
ROCE-128.38%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio2.23

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-33.0M$-80.0M$-106.0M$-141.0M$-95.0M
Net Profit$-32.0M$-76.0M$-97.0M$-24.0M$-91.0M
EPS$-0.82$-1.90$-2.32$-1.46$-1.88
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets————$118.0M
Total Liabilities————$44.0M
Cash————$96.0M
Borrowings$0$0$0$0$0

Latest News

Data I/O And 2 Other Promising Penny Stocks To Watch Simply Wall St. · May 29, 2026 Filana Therapeutics Reports Q1 2026 Financial Results and Business Update GlobeNewswire · May 7, 2026 Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII GlobeNewswire · May 5, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow————$-32.0M
Investing Cash Flow————$-1.0M
Financing Cash Flow————$0
Net Cash Flow————$-33.0M
Free Cash Flow$0$0$0$0$-33.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-147.73%
Quick Ratio2.19
Interest Coverage—
Return 1Y-48.31%
Return 3Y-95.12%
Return 5Y-98.66%

Ownership

Insiders Held2.05%
Institutions Held28.59%
Institutions Float Held29.19%
Institutional HolderSharesReport Date
Marshall Wace LLP2,012,5432026-03-31
Two Sigma Investments, LP1,988,8142026-03-31
Vanguard Capital Management LLC1,930,9432026-03-31
Blackrock Inc.1,414,5142026-03-31
Geode Capital Management, LLC596,2422026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About FLNA

FLNA is led by CEO Richard Jon Barry, employs 20 people, headquartered in US, publicly traded since 2000.

FLNA stock trades at $0.99 with a market capitalization of $47.96M. The stock is valued at a price-to-earnings (P/E) ratio of -0.66, price-to-book of 0.82, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.87 and $4.98, and currently trades 80.1% below its 52-week high.

On profitability, FLNA generates a return on equity (ROE) of -122.97%, return on capital employed of -128.38%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides